Stem Cell Trial Progressing

StemCells, Inc. announced that it has transplanted purified human neural stem cells (HuCNS-SC®) into the first five of eight patients in the final cohort of its 16-patient Phase I/II trial for dry AMD. The trial is currently enrolling patients at five centers at: Retina Foundation of the Southwest, Dallas, TX (214) 363-3911 Byers Eye Institute [Read More]

Blindness and Visual Impairment Rates Have Fallen

234 out of 15,000 studies between 1980 and 2012 have shown that rates of blindness and visual impairment have decreased significantly in developed countries during the past two decades. Macular degeneration now appears to be the leading cause of chronic vision loss, surpassing cataracts and glaucoma. The most common cause of partial vision impairment continues [Read More]

Effects of AREDS Supplements Up In Smoke

Canadian researchers recently conducted a telephone survey to evaluate patients’ understanding of the importance and adherence to various lifestyle and Age-Related Eye Disease Study (AREDS) supplement recommendations. Tobacco smoking was one of the lifestyle choices looked at. Of the 92 patients contacted, 98% knew about the AREDS formula, with 74% agreeing that high doses of [Read More]

Vision Loss and Social Security Disability

Decreased vision leads to detrimental, life-altering complications, which often include loss of employment and increased difficulty carrying out everyday activities. If vision loss has negatively impacted your life, you may qualify for Social Security disability payments. There are two ways to file. If you have severe vision loss in both eyes and your vision in [Read More]